Scientific harassment by pharmaceutical companies: time to stop.
作者信息
Hailey D
机构信息
Alberta Heritage Foundation for Medical Research, Edmonton.
出版信息
CMAJ. 2000 Jan 25;162(2):212-3.
Abstract
摘要
相似文献
1
Scientific harassment by pharmaceutical companies: time to stop.
CMAJ. 2000 Jan 25;162(2):212-3.
2
The changing environment for technological innovation in health care.
Baxter Health Policy Rev. 1996;2:267-315.
3
[Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages].
Ned Tijdschr Geneeskd. 1999 Jul 24;143(30):1572-6.
4
Researchers left to guess at outcomes of most cancer clinical trials.
J Natl Cancer Inst. 2009 Jan 21;101(2):72-4. doi: 10.1093/jnci/djn495. Epub 2009 Jan 13.
5
The state of innovation in drug development.
Clin Pharmacol Ther. 2008 Feb;83(2):227-30. doi: 10.1038/sj.clpt.6100479.
6
7
Bias in the design, interpretation, and publication of industry-sponsored clinical research.
Minn Med. 2008 Jun;91(6):46-7.
8
Industry sponsorship in research and publishing: who is really to blame for perceived bias?
Ann Pharmacother. 2004 Apr;38(4):714-6. doi: 10.1345/aph.1D617. Epub 2004 Feb 24.
9
America's other drug problem: how the drug industry distorts medicine and politics.
New Repub. 2002 Dec 16;227(25):27-41.
10
Small study on industry trial sponsorship leads to big questions about quality and bias.
J Natl Cancer Inst. 2007 Jul 4;99(13):988-90. doi: 10.1093/jnci/djm057. Epub 2007 Jun 27.
引用本文的文献
1
Public welfare agenda or corporate research agenda?
Mens Sana Monogr. 2005 Mar;3(1):41-80. doi: 10.4103/0973-1229.27878.
2
Finer nuances of clinical study agreements for research trials.
Indian J Ophthalmol. 2008 Jul-Aug;56(4):267-8. doi: 10.4103/0301-4738.41409.
3
Scientific data from clinical trials: investigators' responsibilities and rights.
World J Surg. 2002 Jun;26(6):637-8. doi: 10.1007/s00268-002-1237-y. Epub 2002 Jun 6.
4
Scientific data from clinical trials: investigators' responsibilities and rights.
J Gastrointest Surg. 2002 May-Jun;6(3):512-3. doi: 10.1016/s1091-255x(02)00031-8.
5
Scientific data from clinical trials: investigators' responsibilities and rights.
Surg Endosc. 2002 Jun;16(6):1019-20. doi: 10.1007/s00464-002-0004-3. Epub 2002 May 3.
6
Dancing with the porcupine: rules for governing the university-industry relationship.
CMAJ. 2001 Sep 18;165(6):783-5.
7
Why randomized controlled trials fail but needn't: a new series is launched.
CMAJ. 2000 May 2;162(9):1301-2.
本文引用的文献
1
Time to put the Canadian Institutes of Health Research on trial.
CMAJ. 1999 Nov 30;161(11):1414-5.
2
The need for greater involvement of regulatory agencies in assessing adverse drug reactions.
CMAJ. 2000 Jan 25;162(2):209-10.
3
Support of clinical trials.
CMAJ. 2000 Jan 25;162(2):189.
4
Drug company threatens legal action over Canadian guidelines.
BMJ. 1999 Nov 27;319(7222):1388. doi: 10.1136/bmj.319.7222.1388a.
5
Fair conduct and fair reporting of clinical trials.
JAMA. 1999 Nov 10;282(18):1766-8. doi: 10.1001/jama.282.18.1766.
6
Time to register randomised trials. The case is now unanswerable.
BMJ. 1999 Oct 2;319(7214):865-6. doi: 10.1136/bmj.319.7214.865.
7
The courts--a challenge to health technology assessment.
Science. 1999 Jul 9;285(5425):203-4. doi: 10.1126/science.285.5425.203.
Zotero 插件